BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3890441)

  • 1. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions.
    Renshaw AA; Nappi D; Cibas ES
    Diagn Cytopathol; 1996 Aug; 15(2):103-7. PubMed ID: 8872430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV
    Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple immunohistochemical method for the detection of prostatic acid phosphatase.
    Lee P; Lam KW; Li CY; Yam LT
    Arch Pathol Lab Med; 1981 Apr; 105(4):205-6. PubMed ID: 7011253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prostatic adenocarcinoma: a cytopathological study of 50 cases.
    Mai KT; Roustan Delatour NL; Assiri A; Al-Maghrabi H
    Diagn Cytopathol; 2007 Feb; 35(2):91-5. PubMed ID: 17230567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates.
    Walts AE; Said JW
    Acta Cytol; 1983; 27(4):408-16. PubMed ID: 6410636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS; Cohen C; Demers LM; Budgeon LR
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
    Lee C; Murphy GP; Chu TM
    Cancer Res; 1980 Apr; 40(4):1245-8. PubMed ID: 7357554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma.
    Pinto MM
    Acta Cytol; 1986; 30(3):240-4. PubMed ID: 3521174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of prostatic carcinoma presenting as a metastatic orbital tumor].
    Sakai H; Igawa T; Saha PK; Nomata K; Yushita Y; Kanetake H; Saito Y
    Hinyokika Kiyo; 1992 Jan; 38(1):77-80. PubMed ID: 1546575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
    Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
    Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM; Culp DA
    Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
    Perrin P; Clairet F; Fleury-Goyon MC; Durand L
    J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of prostate metastatic to the skin diagnosed by immunoperoxidase staining.
    Spiller JC; Hall JC; Watson KR
    Mo Med; 1991 Sep; 88(9):642-4. PubMed ID: 1745221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.